TGFB1 and osteoporosis: Since DM patients have lower bone mineral density and are at a higher risk of developing osteoporosis [38], the long-term consequences of the HTP-dependent activation of the TGF-β pathway in immune cells on the development and progression of osteoporosis in DMHTP patients should be explored in detail in future experimental and clinical studies.